This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.
Jennifer Putnam
Advertisement
Jennifer Putnam is AR&D supervisor II, Perrigo
Articles by Jennifer Putnam
Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
Advertisement
Latest Updated Articles
Understanding Concomitant Components in Pharmaceutical ExcipientsFebruary 2nd 2021
Mitigating the Risk from Excipient VariabilityAugust 2nd 2022
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Shilpa CDMO to Launch as Dedicated Complex Small-Molecule Contract Development and Manufacturing Brand at CPHI Milan
2
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
3
Technology Transfer: Success Drivers and Obstacles Explained
4
PharmTech Weekly Roundup—September 11, 2026
5